13F-HR filed by HealthCor Management, L.P.
HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 73 holding rows worth $2,317,469,000.
- Accession
- 0001343781-21-000007
- Filer
- CIK 1343781
- Filed
- 2021-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 73 entries on the cover page, a total value of $2,317,469,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,317,469,000 with VALUE read as thousands by filing date, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | 110122108 | COM | 3,584,160 | $212,075,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 1,278,228 | $140,017,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 466,830 | $132,108,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 896,680 | $107,108,000 | thousands by filing date | |
| PETCO HEALTH AND WELLNESS CO | 71601V105 | COM | 4,944,450 | $104,328,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 897,646 | $100,034,000 | thousands by filing date | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 2,249,972 | $94,071,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 442,470 | $88,220,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 612,480 | $76,774,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 1,707,681 | $74,096,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 1,084,240 | $72,037,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 529,230 | $61,592,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 982,630 | $61,228,000 | thousands by filing date | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 460,790 | $59,999,000 | thousands by filing date | |
| Stryker Corporation | 863667101 | COM | 222,510 | $58,680,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 237,360 | $57,612,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 3,849,470 | $55,317,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 652,150 | $51,644,000 | thousands by filing date | |
| WELLTOWER INC COM | 95040Q104 | REIT | 617,480 | $50,880,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 330,590 | $48,385,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 348,680 | $48,247,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 445,739 | $42,751,000 | thousands by filing date | |
| Cigna Corporation | 125523100 | COM | 211,780 | $42,390,000 | thousands by filing date | |
| VENTAS INC COM | 92276F100 | REIT | 725,010 | $40,028,000 | thousands by filing date | |
| CANO HEALTH INC | 13781Y103 | COM | 2,754,730 | $34,930,000 | thousands by filing date | |
| BECTON DICKINSON & CO | 075887109 | COM | 140,540 | $34,548,000 | thousands by filing date | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 46,730 | $31,096,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 130,290 | $23,633,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,214,670 | $23,212,000 | thousands by filing date | |
| IDEXX LABS INC COM | 45168D104 | Stock | 35,800 | $22,264,000 | thousands by filing date | |
| LONGVIEW ACQUISITION CORP II | 54319Q105 | COM CL A | 2,135,900 | $21,124,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 493,502 | $20,076,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 267,000 | $18,364,000 | thousands by filing date | call |
| ZOETIS INC CL A | 98978V103 | Stock | 83,060 | $16,125,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 2,555,908 | $15,796,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 434,500 | $15,529,000 | thousands by filing date | |
| CVS Health Corporation | 126650100 | COM | 173,800 | $14,749,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 386,190 | $13,123,000 | thousands by filing date | |
| RESEARCH ALLIANCE CORP II | 760873109 | CMN | 1,324,800 | $13,049,000 | thousands by filing date | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 250,000 | $12,270,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 82,183 | $11,416,000 | thousands by filing date | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 119,600 | $8,975,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 128,450 | $7,613,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S108 | CL A SHS | 744,000 | $7,254,000 | thousands by filing date | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 23,690 | $6,467,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 184,700 | $5,735,000 | thousands by filing date | |
| ORION ACQUISITION CORP | 68626A108 | CMN | 547,385 | $5,310,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 75,000 | $5,159,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITN CORP | G31658100 | CLASS A ORD SHS | 500,000 | $4,940,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 1,200,000 | $4,812,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 339,951 | $4,290,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 164,912 | $3,638,000 | thousands by filing date | |
| ABG ACQUISITION CORP I | G00496102 | CL A SHS | 329,400 | $3,208,000 | thousands by filing date | |
| OMEGA ALPHA SPAC | G6749V107 | CL A | 271,032 | $2,638,000 | thousands by filing date | |
| SARISSA CAPITAL ACQUISITN CO | G7823W128 | UNIT 10/23/2027 | 262,150 | $2,622,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 70,050 | $2,443,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W114 | UNIT 10/23/2027 | 234,180 | $2,321,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 49,640 | $2,306,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 81,500 | $2,271,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 9,890 | $1,750,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 70,898 | $1,560,000 | thousands by filing date | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 37,400 | $1,427,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 7,510 | $1,418,000 | thousands by filing date | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 42,800 | $1,402,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 140,680 | $1,372,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 36,580 | $1,282,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 7,280 | $1,176,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 200,000 | $1,134,000 | thousands by filing date | |
| ATAIBECKLEY INC | N0731H103 | Equity | 75,000 | $1,109,000 | thousands by filing date | |
| LONGVIEW ACQUISITION CORP II | 54319Q113 | *W EXP 99/99/999 | 427,178 | $551,000 | thousands by filing date | |
| CM LIFE SCIENCES III INC | 125841114 | *W EXP 04/30/202 | 99,998 | $214,000 | thousands by filing date | |
| ORION ACQUISITION CORP | 68626A116 | WTS | 137,305 | $88,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 82,663 | $59,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001343781-21-000007 | this filing | 2021-11-15 | acceptance time not in the bulk data set |